Company Filing History:
1 out of 2 
1 out of 6 
Years Active: 2021
Title: Hyon Ha Lee: Innovator in Rheumatoid Arthritis Treatment
Introduction
Hyon Ha Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment of rheumatoid arthritis. His innovative work has led to the development of a unique strain that holds promise for alleviating this debilitating condition.
Latest Patents
Hyon Ha Lee holds a patent for the RAPO strain, which is designed for alleviating, treating, or preventing rheumatoid arthritis. The patent, titled "RAPO strain for alleviating, treating or preventing rheumatoid arthritis and composition containing the same," discloses a novel RAPO (Accession No.: KCTC 13773BP) and a composition that incorporates this strain. This advancement represents a significant step forward in the therapeutic options available for patients suffering from rheumatoid arthritis.
Career Highlights
Throughout his career, Hyon Ha Lee has been associated with reputable institutions, including The Catholic University of Korea and Bifido Co., Ltd. His work in these organizations has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Hyon Ha Lee has worked alongside notable colleagues such as Geun Eog Ji and Yun Ju Jeong. Their combined expertise has contributed to the advancement of research in the area of rheumatoid arthritis treatment.
Conclusion
Hyon Ha Lee's innovative contributions to the field of rheumatoid arthritis treatment through his patented RAPO strain highlight his dedication to improving patient outcomes. His work continues to inspire advancements in medical research and treatment options.